Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-02

Clinical Trial Update: Efficacy and Safety of Artesunate-amodiaquine and Artemether-lumefantrine for the Treatment of Malaria in Cameroon [Phase 4]

View source ↗

Summary

A Phase 4 trial update assessing efficacy and safety of artesunate-amodiaquine and artemether-lumefantrine for falciparum malaria in Cameroon.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemether-lumefantrine (artemether and lumefantrine)
  • Artesunate-amodiaquine (artesunate-amodiaquine)

Snippet

Sponsor: University of Yaounde 1 | Conditions: Falciparum Malaria | Phase 4 | Status: UNKNOWN